Cumberland Pharmaceuticals Inc. Noncash or Part Noncash Acquisition, Fixed Assets Acquired
Cumberland Pharmaceuticals Inc. (CPIX) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $1.27 million for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2015-11-06
- Cumberland Pharmaceuticals Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2015-09-30 was -$283.26K, a 154.05% decline year-over-year.
- Cumberland Pharmaceuticals Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2015-06-30 was -$42.92K, a 107.65% decline year-over-year.
- Cumberland Pharmaceuticals Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2015-03-31 was $1.59M.
- Cumberland Pharmaceuticals Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2014-09-30 was $524.03K.
| Period end | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 9 month |
|---|---|---|---|
| 2015-09-30 | -$283.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$326.18K derived: sum of 2 quarters · filed 2015-11-06 | $1.27M 10-Q · filed 2015-11-06 |
| 2015-06-30 | -$42.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $1.55M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $1.59M 10-Q · filed 2015-05-15 | ||
| 2014-09-30 | $524.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $1.09M derived: sum of 2 quarters · filed 2015-11-06 | $974.81K 10-Q · filed 2015-11-06 |
| 2014-06-30 | $560.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $450.78K 10-Q · filed 2015-08-07 | |
| 2014-03-31 | -$110.20K 10-Q · filed 2015-05-15 | ||
| 2013-09-30 | -$19.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $70.25K derived: sum of 2 quarters · filed 2014-11-07 | $230.52K 10-Q · filed 2014-11-07 |
| 2013-06-30 | $89.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $249.63K 10-Q · filed 2014-08-08 | |
| 2013-03-31 | $160.27K 10-Q · filed 2014-05-12 | ||
| 2012-09-30 | $21.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $12.58K derived: sum of 2 quarters · filed 2013-11-06 | $95.27K 10-Q · filed 2013-11-06 |
| 2012-06-30 | -$9.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $73.46K 10-Q · filed 2013-08-09 | |
| 2012-03-31 | $82.70K 10-Q · filed 2013-05-08 | ||
| 2011-06-30 | $40.07K 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |